Search
TELA Bio Inc
TELAAdd to Watchlist
0.970USD
+0.065+7.18%
Close 09-11 16:00（ET）
42.59MMarket Cap
LossP/E TTM
More Details of TELA Bio Inc Company
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.
TELA Bio Inc Profile
Ticker SymbolTELA
Company nameTELA Bio Inc
IPO dateNov 08, 2019
CEOKoblish (Antony)
Number of employees209
Security typeOrdinary Share
Fiscal year-endNov 08
Address1 Great Valley Parkway, Suite 24
CityMALVERN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19355
Phone14843202930
Websitehttps://www.telabio.com/
Ticker SymbolTELA
IPO dateNov 08, 2019
CEOKoblish (Antony)
Company Executives of TELA Bio Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
532.50K
--
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
396.29K
-23.08%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
52.35K
-279.66%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
23.60K
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Director
Independent Director
23.60K
--
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
18.47K
+23.01%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
18.47K
+23.01%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
18.47K
+23.01%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.68K
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
Chief Executive Officer, Principal Executive Officer and Principal Financial Officer, Director
532.50K
--
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
396.29K
-23.08%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
110.92K
+44.67%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
52.35K
-279.66%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
23.60K
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Director
Independent Director
23.60K
--
FAQs
Who are the top five shareholders of TELA Bio Inc?
The top five shareholders of TELA Bio Inc are: Ms. Heather C. Getz, CPA
How many institutions hold shares of TELA Bio Inc (TELA)?
As of 2026Q1, 163 institutions hold shares of TELA Bio Inc, with a combined market value of approximately 32.85M, accounting for 73.39% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -6147477.00.
What is the biggest source of revenue for TELA Bio Inc?
In 2026Q1, the OviTex business generated the highest revenue for TELA Bio Inc, amounting to 13.31M and accounting for 68.99% of total revenue.